CAMP4 Therapeutics Corp. (CAMP)
4.26
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 11, 12:20
CAMP4 Therapeutics EPS Diluted (Quarterly) : -0.3668 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3668 |
| June 30, 2026 | -0.5788 |
| March 31, 2026 | -0.3165 |
| December 31, 2025 | -0.7762 |
| September 30, 2025 | -0.5536 |
| June 30, 2025 | -0.6244 |
| March 31, 2025 | -0.6169 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.6592 |
| September 30, 2024 | -0.6688 |
| June 30, 2024 | -0.6448 |
| March 31, 2024 | -0.6176 |
| December 31, 2023 | -0.666 |
| September 30, 2023 | -0.5801 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.96M |
| Revenue (Quarterly) | 1.899M |
| Total Expenses (Quarterly) | 30.86M |
| Enterprise Value | 152.92M |
| Gross Profit Margin (Quarterly) | 72.46% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -47.85% |
| Normalized Earnings Yield | -27.99 |